LENZ Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2021 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
LENZ Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2021 to Q1 2025.
- LENZ Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$16M, a 33% increase year-over-year.
- LENZ Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$59.4M, a 1.64% increase from 2023.
- LENZ Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$60.4M, a 31.4% increase from 2022.
- LENZ Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$88M, a 66.5% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)